Pierre Dönnes

5PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Innate immunityPharmacogenomicsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 05, 2024
A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice.

Aman Mebrahtu, Ida Laurén, Rosanne Veerman

|Aug 28, 2024
Enhancing Maturation and Translatability of Human Pluripotent Stem Cell-Derived Cardiomyocytes through a Novel Medium Containing Acetyl-CoA Carboxylase 2 Inhibitor.

Cláudia Correia, Jonas Christoffersson, Sandra Tejedor

|Aug 30, 2021
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.

Sebastian Havervall, Henry Ng, August Jernbom Falk

|Oct 30, 2020
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium.

Signe Hässler, Delphine Bachelet, Julianne Duhaze

|Mar 03, 2018
Population-specific design of de-immunized protein biotherapeutics.

Benjamin Schubert, Charlotta Schärfe, Pierre Dönnes

Pageof 1

Frequent Collaborators

2 joint publications

Sara Mangsbo

2 joint publications

Martin Lord

1 joint publications

Benjamin Schubert

1 joint publications

Oliver Kohlbacher